2022 Q4 Form 20-F Financial Statement
#000117891323001145 Filed on March 28, 2023
Income Statement
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| Revenue | $33.03M | $122.7M | $40.97M |
| YoY Change | -19.39% | -15.7% | 4.82% |
| Cost Of Revenue | $11.13M | $39.83M | $12.52M |
| YoY Change | -11.04% | -10.6% | 7.62% |
| Gross Profit | $21.90M | $82.91M | $28.46M |
| YoY Change | -23.06% | -17.95% | 3.63% |
| Gross Profit Margin | 66.29% | 67.55% | 69.45% |
| Selling, General & Admin | $16.91M | $65.70M | $19.17M |
| YoY Change | -11.79% | -2.64% | 19.74% |
| % of Gross Profit | 77.23% | 79.25% | 67.36% |
| Research & Development | $12.65M | $50.07M | $13.01M |
| YoY Change | -2.77% | 5.95% | 3.13% |
| % of Gross Profit | 57.75% | 60.4% | 45.7% |
| Depreciation & Amortization | $2.528M | $7.352M | $2.195M |
| YoY Change | 15.17% | 31.87% | 33.03% |
| % of Gross Profit | 11.55% | 8.87% | 7.71% |
| Operating Expenses | $29.55M | $115.8M | $32.18M |
| YoY Change | -8.15% | 1.05% | 12.42% |
| Operating Profit | -$7.659M | -$32.87M | -$3.717M |
| YoY Change | 106.05% | 142.96% | 220.43% |
| Interest Expense | $796.0K | $2.134M | $176.0K |
| YoY Change | 352.27% | 414.22% | -48.24% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $2.134M | ||
| YoY Change | -2907.89% | ||
| Pretax Income | -$6.264M | -$30.14M | -$3.541M |
| YoY Change | 76.9% | 128.49% | 337.16% |
| Income Tax | $474.0K | $1.895M | $489.0K |
| % Of Pretax Income | |||
| Net Earnings | -$6.738M | -$32.03M | -$4.030M |
| YoY Change | 67.2% | 112.97% | 139.88% |
| Net Earnings / Revenue | -20.4% | -26.1% | -9.84% |
| Basic Earnings Per Share | -$0.87 | ||
| Diluted Earnings Per Share | -$0.18 | -$0.87 | -$110.6K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 37.37M shares | 36.98M shares | |
| Diluted Shares Outstanding | 36.98M shares |
Balance Sheet
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $85.35M | $85.35M | $83.97M |
| YoY Change | 1.65% | 1.65% | -14.32% |
| Cash & Equivalents | $12.30M | $12.30M | $11.72M |
| Short-Term Investments | $73.06M | $73.06M | $72.25M |
| Other Short-Term Assets | $1.050M | $1.050M | $1.480M |
| YoY Change | -29.05% | -83.82% | 23.33% |
| Inventory | $13.26M | $13.26M | $11.09M |
| Prepaid Expenses | $4.560M | $4.029M | |
| Receivables | $44.17M | $44.17M | $30.83M |
| Other Receivables | $7.985M | $7.985M | $8.490M |
| Total Short-Term Assets | $151.8M | $151.8M | $135.9M |
| YoY Change | 11.75% | 11.75% | -7.39% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $19.62M | $19.62M | $23.51M |
| YoY Change | -16.54% | -16.54% | 42.5% |
| Goodwill | $31.83M | $31.68M | |
| YoY Change | 0.47% | ||
| Intangibles | $3.511M | $3.455M | |
| YoY Change | 1.62% | ||
| Long-Term Investments | $0.00 | $0.00 | $215.0K |
| YoY Change | -100.0% | -100.0% | 7.5% |
| Other Assets | $1.235M | $1.235M | $2.046M |
| YoY Change | -39.64% | -39.64% | -46.16% |
| Total Long-Term Assets | $61.14M | $61.14M | $67.56M |
| YoY Change | -9.5% | -9.5% | 23.05% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $151.8M | $151.8M | $135.9M |
| Total Long-Term Assets | $61.14M | $61.14M | $67.56M |
| Total Assets | $213.0M | $213.0M | $203.4M |
| YoY Change | 4.69% | 4.69% | 0.9% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $11.66M | $11.66M | $3.940M |
| YoY Change | 195.96% | 195.96% | 87.62% |
| Accrued Expenses | $2.542M | $2.542M | $17.42M |
| YoY Change | -85.41% | -90.73% | 2.48% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $60.60M | $60.60M | $55.11M |
| YoY Change | 9.96% | 9.96% | -6.43% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $39.58M | $39.58M | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $10.80M | $10.80M | $22.29M |
| YoY Change | -51.54% | -51.54% | 76.93% |
| Total Long-Term Liabilities | $50.38M | $50.38M | $22.29M |
| YoY Change | 125.99% | 125.99% | 76.93% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $60.60M | $60.60M | $55.11M |
| Total Long-Term Liabilities | $50.38M | $50.38M | $22.29M |
| Total Liabilities | $111.0M | $111.0M | $77.41M |
| YoY Change | 43.37% | 43.37% | 8.41% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$197.0M | -$165.0M | |
| YoY Change | 19.41% | ||
| Common Stock | $954.0K | $929.0K | |
| YoY Change | 2.69% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $3.998M | $3.998M | |
| YoY Change | 0.0% | ||
| Treasury Stock Shares | 816.0K shares | 816.0K shares | |
| Shareholders Equity | $102.0M | $102.0M | $126.0M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $213.0M | $213.0M | $203.4M |
| YoY Change | 4.69% | 4.69% | 0.9% |
Cashflow Statement
| Concept | 2022 Q4 | 2022 | 2021 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$6.738M | -$32.03M | -$4.030M |
| YoY Change | 67.2% | 112.97% | 139.88% |
| Depreciation, Depletion And Amortization | $2.528M | $7.352M | $2.195M |
| YoY Change | 15.17% | 31.87% | 33.03% |
| Cash From Operating Activities | -$9.686M | -$32.56M | -$10.53M |
| YoY Change | -8.01% | 289.07% | 81.22% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $1.507M | $5.642M | -$3.051M |
| YoY Change | -149.39% | -173.83% | 50.3% |
| Acquisitions | $500.0K | ||
| YoY Change | |||
| Other Investing Activities | $14.90M | -$870.0K | $19.49M |
| YoY Change | -23.54% | -165.96% | 48.87% |
| Cash From Investing Activities | $13.39M | -$6.512M | $16.44M |
| YoY Change | -18.51% | 2.99% | 48.61% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $1.000K | $251.0K | $151.0K |
| YoY Change | -99.34% | -91.07% | -5.63% |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.000K | 39.66M | 151.0K |
| YoY Change | -99.34% | 1310.71% | -5.63% |
| NET CHANGE | |||
| Cash From Operating Activities | -9.686M | -32.56M | -10.53M |
| Cash From Investing Activities | 13.39M | -6.512M | 16.44M |
| Cash From Financing Activities | 1.000K | 39.66M | 151.0K |
| Net Change In Cash | 3.708M | 578.0K | 6.058M |
| YoY Change | -38.79% | -104.86% | 11.98% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$9.686M | -$32.56M | -$10.53M |
| Capital Expenditures | $1.507M | $5.642M | -$3.051M |
| Free Cash Flow | -$11.19M | -$38.21M | -$7.478M |
| YoY Change | 49.68% | 5148.21% | 97.83% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022 | allt |
Patent Use Right Period
PatentUseRightPeriod
|
P8Y | |
| CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
22 Hanagar Street | |
| CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Neve Ne’eman Industrial Zone B | |
| CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Hod-Hasharon | |
| CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
4501317 | |
| CY2022 | dei |
Entity Address Country
EntityAddressCountry
|
IL | |
| CY2022 | dei |
Auditor Firm
AuditorFirmId
|
1281 | |
| CY2022 | dei |
Auditor Name
AuditorName
|
KOST FORER GABBAY & KASIERER | |
| CY2022 | dei |
Auditor Location
AuditorLocation
|
Tel-Aviv, Israel | |
| CY2022Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
0 | usd |
| CY2021Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
215000 | usd |
| CY2021Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
816000 | shares |
| CY2022Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
816000 | shares |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
130152000 | usd |
| CY2021 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
125000 | usd |
| CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd |
| CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-0 | usd |
| CY2020 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-18000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
55000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-4902000 | usd |
| CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
7272000 | usd |
| CY2022 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
7830000 | usd |
| CY2021 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
13495000 | usd |
| CY2020 | us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
41883000 | usd |
| CY2022Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
132000 | usd |
| CY2022 | allt |
Acquisition Costs Recorded To Operating Expenses
AcquisitionCostsRecordedToOperatingExpenses
|
49000 | usd |
| CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="line-height:1.25"> <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"> <tr> <td style="width:56.7pt"> </td> <td style="vertical-align:top;width:28.5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>a.</span></span></span></td> <td style="vertical-align:top;text-align:justify;width:auto"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates:</span></span></p> </td> </tr> </table> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></span></span></span></div> </div> | |
| CY2022Q4 | us-gaap |
Time Deposits Weighted Average Interest Rate Maturities Year One
TimeDepositsWeightedAverageInterestRateMaturitiesYearOne
|
0.0405 | pure |
| CY2021Q4 | us-gaap |
Time Deposits Weighted Average Interest Rate Maturities Year One
TimeDepositsWeightedAverageInterestRateMaturitiesYearOne
|
0.0071 | pure |
| CY2021Q4 | allt |
Short Term Bank Deposits Hedging Transactions
ShortTermBankDepositsHedgingTransactions
|
5000000 | usd |
| CY2022Q4 | allt |
Short Term Bank Deposits Hedging Transactions
ShortTermBankDepositsHedgingTransactions
|
5000000 | usd |
| CY2022 | allt |
Impairment Of Long Lived Assets And Intangible Assets Subject To Amortization
ImpairmentOfLongLivedAssetsAndIntangibleAssetsSubjectToAmortization
|
<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>l.</span></span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Impairment of long-lived assets, Right-of-use assets, and intangible assets subject to amortization:</span></span></span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property and equipment, Right-of-use assets, and intangible assets subject to amortization are reviewed for impairment in accordance with ASC No. 360, "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. </span></span></span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives. </span></span></span></div> <div/> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Some of the acquired intangible assets are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer relationships as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis.</span></span></span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25;margin-bottom:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has performed an annual impairment analysis as of December 31, 2022 and determined that there were no circumstances indicate the asset’s carrying value may not be recoverable. During the years 2022, 2021 and 2020, no impairment losses were recorded.</span></span></span></span></div> </div> | |
| CY2022 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
1863000 | usd |
| CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div style="line-height:1.25"> <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>s.</span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risks:</span></span></p> </td> </tr> </table> </div> <div style="margin-left:85.05pt;line-height:1.25"> </div> <div style="margin-left:85.05pt;line-height:1.25"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, short-term bank deposits, trade receivables and derivative instruments.</span></span></span></p> <p style="margin:0pt"> </p> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits in major U.S. and Israeli banks. Such investments in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the cash and cash equivalents and short-term bank deposits may be redeemed upon demand, and therefore, bear minimal risk.</p> <p style="margin:0pt"> </p> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">Marketable securities include investments in dollar linked corporate and government bonds. Marketable securities consist of highly liquid debt instruments with high credit standing. The Company’s investment policy, approved by the Board of Directors, limits the amount the Group may invest in any one type of investment or issuer, thereby reducing credit risk concentrations. Management believes that the portfolio is well diversified and, accordingly, minimal credit risk exists with respect to these marketable debt securities.</p> </div> <div/> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company's trade receivables are derived from sales to customers located in EMEA, as well as in APAC, Latin America and the United States. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and establishes an allowance for credit losses on a specific basis. Allowance for credit losses amounted to $ 2,908 and $ 2,398 as of December 31, 2022 and 2021, respectively.</span></span></span></span> <p style="margin:0pt"> </p> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">As of 31.12.2022 we have past due of $15 million out of it approximatly $10.1 million past due receivables from two resellers in Africa and Latin America.</p> <p style="margin:0pt"> </p> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The Company utilizes foreign currency forward contracts to protect against risk of overall changes in exchange rates for some of its currencies exposure. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financial institutions and its exposure is limited to the amount of any asset resulting from the forward contracts.</p> </div> </div> | |
| CY2022 | allt |
Proceeds From Past Due Receivables
ProceedsFromPastDueReceivables
|
10100000 | usd |
| CY2022Q4 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.185 | pure |
| CY2022 | us-gaap |
Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
|
<div> <div style="line-height:1.25"> <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>y.</span></span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivatives and hedging:</span></span></p> </td> </tr> </table> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company accounts for derivatives and hedging based on Accounting Standards Codifiation No. 815, "Derivatives and Hedging" ("ASC No. 815").</span></span></span></span> <p style="margin:0pt"> </p> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company accounts for its derivative instruments as either assets or liabilities and carries them at fair value. Derivative instruments that are not designated and qualified as hedging instruments must be adjusted to fair value through earnings. For highly effective derivative instruments that hedge the exposure to variability in expected future cash flows that are designated as cash flow hedges. Gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) in shareholders' equity and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.</span></span></span></span></p> </div> </div> | |
| CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
4293000 | usd |
| CY2022Q4 | us-gaap |
Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
|
23000 | usd |
| CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
656000 | usd |
| CY2022Q4 | us-gaap |
Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
|
901000 | usd |
| CY2022Q4 | allt |
Net Assets Fair Value Disclosure
NetAssetsFairValueDisclosure
|
2759000 | usd |
| CY2021Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
11531000 | usd |
| CY2021Q4 | us-gaap |
Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
|
980000 | usd |
| CY2021Q4 | us-gaap |
Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
|
78000 | usd |
| CY2021Q4 | allt |
Net Assets Fair Value Disclosure
NetAssetsFairValueDisclosure
|
12433000 | usd |
| CY2022 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-503000 | usd |
| CY2021 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
70000 | usd |
| CY2022 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
|
-3674000 | usd |
| CY2021 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
|
700000 | usd |
| CY2022Q4 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
|
11944000 | usd |
| CY2021Q4 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
|
22275000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
802000 | usd |
| CY2022Q4 | allt |
Finite Lived Intangible Assets Amortization Expense After Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo
|
495000 | usd |
| CY2022 | us-gaap |
Lease Cost
LeaseCost
|
3784000 | usd |
| CY2021 | us-gaap |
Lease Cost
LeaseCost
|
3141000 | usd |
| CY2020 | us-gaap |
Lease Cost
LeaseCost
|
3282000 | usd |
| CY2022 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
82000 | usd |
| CY2022 | allt |
Schedule Of Weighted Average Remaining Lease Term And Discount Rate
ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRate
|
<div> <div style="line-height:1.25"> </div> <div style="margin-left:90pt"> <table border="0" cellpadding="0" cellspacing="0" style="width:88%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:top" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:top" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average remaining lease term</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="text-align:right;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1 years</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="text-align:right;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.9 years</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:top;width:76%" valign="bottom"> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average discount rate</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.49</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.39</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div> </td> </tr> </table> </div> </div> | |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2553000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2090000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
526000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
21000 | usd |
| CY2022 | us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
126000 | usd |
| CY2022Q4 | allt |
Bank Guarantees
BankGuarantees
|
576000 | usd |
| CY2022Q4 | allt |
Guarantees In Favor Of Lease
GuaranteesInFavorOfLease
|
411000 | usd |
| CY2021Q4 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
2600000 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | shares |
| CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
10000 | usd |
| CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
3392000 | usd |
| CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
4226000 | usd |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
10000 | usd |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
3479000 | usd |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
4568000 | usd |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
93000 | usd |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
4113000 | usd |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1437000 | usd |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
15000 | shares |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y4M2D | |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P1Y4M2D | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
487839 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
487839 | shares |
| CY2022 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | usd |
| CY2021 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | usd |
| CY2022 | allt |
Tax Benefits Description
TaxBenefitsDescription
|
The period of tax benefits, detailed above, is limited to the earlier of 12 years from the commencement of production, or 14 years from the approval date. | |
| CY2022 | allt |
Tax Exempt Period
TaxExemptPeriod
|
P2Y | |
| CY2022 | allt |
Dividend Withholding Tax Rate
DividendWithholdingTaxRate
|
0.15 | pure |
| CY2022 | allt |
Expense Deductible Period
ExpenseDeductiblePeriod
|
P3Y | |
| CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4116000 | usd |
| CY2020 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
0 | usd |
| CY2022 | allt |
Other Expenses And Exchange Rate Differences
OtherExpensesAndExchangeRateDifferences
|
195000 | usd |
| CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | usd |
| CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-2000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
42000000 | usd |
| CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
81510000 | usd |
| CY2022Q4 | us-gaap |
Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
|
4823000 | usd |
| CY2022 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
171000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
943000 | usd |
| CY2022 | allt |
Additions To Provision During Period
AdditionsToProvisionDuringPeriod
|
100000 | usd |
| CY2021Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
118000 | usd |
| CY2022Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
93000 | usd |
